A good to moderate European League Against Rheumatism (EULAR) response was achieved by significantly more rituximab treated patients compared to patients treated with methotrexate alone (Table 9).

Table 3 lists the number and percentage of patients from the specific 24-week clinical study conducted 28 with Prometax in patients with dementia associated with Parkinson’ s disease with pre-defined adverse events that may reflect worsening of parkinsonian symptoms.

39 Table 3 lists the number and percentage of patients from the specific 24-week clinical study conducted with Prometax in patients with dementia associated with Parkinson’ s disease with pre-defined adverse events that may reflect worsening of parkinsonian symptoms.

In other clinical trials with acquired antithrombin deficient cardiac surgery patients (n=118) and healthy volunteers (n=102), undesirable effects reported to be related to treatment with ATryn that were observed more than once are listed by System Organ Class in the table below.

The update of the CPV codes and structure should be reflected in the illustrative tables showing the correspondence between the CPV and the Provisional Central Product Classification (CPC Prov.) of the United Nations, the General Industrial Classification of Economic Activities within the European Communities (NACE Rev. 1) and the Combined Nomenclature (CN).

The quantities of paddy rice eligible for intervention in the 2003/04 marketing year shall be broken down into two tranches for the producer Member States, and a shared tranche for the Community as a whole, integrating all the available quantities not used by this period, in accordance with the table shown in Annex IV.";

Finally, the CHMP noted the data and the responses submitted by the MAH with regards to safety signals, both in normal and elderly patients and agreed with the revised and corrected tables on CVAEs and ADRs.

Member States applying the output approach to GDP shall draw up a table of all such adjustments and calculations by branch following NACE-CLIO R44 or, if this is not possible, at the level of aggregation used for their calculations and at least at the level of NACE-CLIO R25 (see ESA, section on classifictions and coding).

Other interactions Interactions between efavirenz and protease inhibitors, antiretroviral agents other than protease inhibitors and other non-antiretroviral medicinal products are listed in Table 2 below (increase is indicated as “↑”, decrease as “↓”, no change as “↔”, and once every 8 or 12 hours as “ q8h” or “ q12h”). If available, 90 % or 95 % confidence intervals are shown in parentheses. Studies were conducted in healthy subjects unless otherwise noted.

Serious bleeding events during the infusion period The following table lists the percent of patients in PROWESS and ENHANCE experiencing serious bleeding events by site of haemorrhage during the study drug infusion period (defined as the duration of infusion plus the next full calendar day following the end of the infusion).

The tolerable negative error in the contents of a prepackage is fixed in accordance with the table below, in which products are divided into two classes ("A" and "B"), as set out in 2.5 and 2.6 below, according to their physical characteristics and/or the packaging processes which they undergo and the values of the nominal quantities.

Interactions between tenofovir disoproxil fumarate and protease inhibitors and antiretroviral agents other than protease inhibitors are listed in Table 1 below (increase is indicated as “↑”, decrease as “↓”, no change as “↔”, twice daily as “ b. i. d.”, and once daily as “ q. d.”).

Tasigna has little or no effect against the majority of other protein kinases examined, including Src, except for the PDGF, Kit and Ephrin receptor kinases, which it inhibits at concentrations within the range achieved following oral administration at therapeutic doses recommended for the treatment of CML (see Table 4).

The variable component which the Portuguese Republic may apply in accordance with Article 1 of Protocol N° 2 to the Agreement to certain products listed in Table I of that Protocol, originating in Iceland, shall be adjusted by the compensatory amount applied in trade between the Community as constituted on 31 December 1985 and Portugal.

Whereas, by means of an exchange of letters of 4 and 5 February 1981, the European Economic Community and the Swiss Confederation agreed on trade concessions regarding processed agricultural products covered by Table II annexed to Protocol 2 of the Agreement of 22 July 1972 concluded between these same parties (1);

The variable component which the Kingdom of Spain may apply in accordance with Article 1 of Protocol N° 2 to the Agreement to certain products listed in Table I of that Protocol, originating in Iceland, shall be adjusted by the compensatory amount applied in trade between the Community as constituted on 31 December 1985 and Spain.

Illustrative tables must also be drawn up showing the correspondence between the CPV and the Statistical Classification of Products by Activity in the EEC (CPA), the Provisional Central Product Classification (CPC Prov.) of the United Nations, the General Industrial Classification of Economic Activities within the European Communities (NACE Rev. 1) and the Combined Nomenclature (CN).

In order to ensure more flexible financial management, Member States which have opted for regionalised rural development programming should have the option of having the total amount of Community support granted to each regional programme set out in a separate decision containing a consolidated table for the entire Member State.

The incidence of on treatment alanine aminotransferase (ALT) flares in the two treatment arms according to AASLD (American Association for the Study of Liver Diseases) definition (ALT elevation > 2x baseline and > 10x ULN) are further described in Table 3 below.

Other interactions Interactions between efavirenz and protease inhibitors, antiretroviral agents other than protease inhibitors and other non-antiretroviral medicinal products are listed in Table 3 below (increase is indicated as “↑”, decrease as “↓”, no change as “↔”, and once every 8 or 12 hours as “ q8h” or “ q12h”).

Acting in accordance with the procedures referred to in Articles 50(2) and 48(3) of Regulation (EC) No 1260/1999, the Commission shall approve any amendments to rural development programming documents, financial table annexed to the decision referred to in the first subparagraph of Article 48(1) and rural development measures included in single programming documents under Objective 2 financed by the EAGGF Guarantee Section whenever they have a bearing on:

The illustrative tables showing the correspondence between the CPV and the Statistical Classification of Products by Activity in the EEC (CPA), the Provisional Central Product Classification (CPC Prov.) of the United Nations, the General Industrial Classification of Economic Activities within the European Communities (NACE Rev. 1) and the Combined Nomenclature (CN) are set out in Annexes II, III, IV and V respectively.

The exchanges of letters of 4 and 5 February 1981 between the European Economic Community and the Swiss Confederation regarding processed agricultural products require certain amendments to be made to Table II annexed to Protocol 2 of the Agreement between the Swiss Confederation and the European Economic Community signed on 22 July 1972.

The manufacturer shall specify the upper temperature limit and the lower temperature limit from any of the values in Table 1 unless otherwise specified in the Annexes MI-001 to MI-010, and indicate whether the instrument is designed for condensing or non-condensing humidity as well as the intended location for the instrument, i.e. open or closed.

Member States may be authorized, in accordance with the procedure laid down in Article 21, not to apply in respect of the production of a given Member State the condition contained in Annex II, section I, point 2, paragraph B (1) for one or more of the species concerned, if it can be assumed from ecological conditions and previous experience that the standards laid down in Annex II, section I, point 2, column 13 of the table are being complied with."

In accordance with the provisions of Commission Decision 97/747/EC of 27 October 1997 fixing the levels and frequencies of sampling provided for by Council Directive 96/23/EC for the monitoring of certain substances and residues thereof in certain animal products(2), the sample size for hen eggs is at least 12 eggs (for bulk lots as well for lots consisting of individual packages, Tables 1 and 2).

In all three phase III studies (see table 2), rivaroxaban significantly reduced the rate of total VTE (any venographically detected or symptomatic DVT, non fatal PE and death) and major VTE (proximal DVT, non fatal PE and VTE-related death), the pre-specified primary and major secondary efficacy endpoints.

Within six weeks following that adaptation the Member States shall communicate to the Commission, for each rural development programme and single programming document for Objective 2 as regard rural development measures financed by the EAGGF-Guarantee Section, a new financial table complying with the adjusted forecasts for the financial year concerned and the allocations fixed by Decision 1999/659/EC as modified.

Table 1 displays the adverse reactions (events reasonably believed to be causally related to the medicinal product) reported in 291 patients with Alzheimer’ s dementia treated in a specific 24-week double-blind, placebo and active-controlled clinical study with Prometax transdermal patches at target dose of 9.5 mg/ 24 h (4.6 mg/ 24 h titrated to 9.5 mg/ 24 h).

The headings in question are D.9 Capital transfers, payable, D.91 Capital taxes and D.99 Other capital transfers, P.53 Acquisitions less disposals of valuables, K.2 Acquisitions less disposals of non-produced non-financial assets, K.21 Acquisitions less disposals of land and other tangible non-produced assets and K.22 Acquisitions less disposals of intangible non-produced assets (production rights, etc.) in Table 4.

Interaction table Interactions between darunavir/ ritonavir and protease inhibitors, antiretroviral agents other than protease inhibitors and other non-antiretroviral medicinal products are listed in the tables below (increase is indicated as “↑”, decrease as “↓”, no change as “↔”, not determined as “ ND”, twice daily as “ b. i. d.”, once daily as “ q. d.” and once every other day as “ q. o. d.”).

In order to make it possible, allowing for the usual uncertainties in filling, to measure the volume of the contents of measuring container bottles with sufficient accuracy, and in particular with the accuracy required by the Directives on prepackages, the maximum permissible errors (positive or negative) in the capacity of a measuring bottle container, i.e. the greatest differences permitted (positive or negative) at a temperature of 20oC and under the control conditions laid down in Annex II, between the actual capacity and the nominal capacity Vn shall be in accordance with the following table:

financial tables covering the entire budget;

XL From 1 January 1978, Table I in Protocol 2 shall be amended as follows:

For the products which are listed both in Table I of Protocol 2 to the Agreement and in Annex I to this

For the products specified in the Tables annexed to this Protocol the basic duties shall be:

In order to take account of differences in the cost of the agricultural products incorporated in the goods specified in the Tables annexed to this Protocol, the Agreement does not preclude:

The European Community and the Governments of Austria, Finland, Liechtenstein, Sweden and Switzerland declare that Appendix 2, Table I, of Protocol 9 is without prejudice to the import ban which they apply for whale products.

The Hellenic Republic shall apply the provisions laid down in the table contained in Article 1 (3) of Protocol 1 to the Agreement to all products covered by Chapters 48 and 49 of the.Common Customs Tariff originating in Iceland and not listed in Annex I.

The difference between the basic duties so defined and the duties applicable on 1 July 1977, which are shown in the Tables annexed to this Protocol, shall be progressively abolished by five reductions of 20 % each to be made on the following dates:

The variable component which the Hellenic Republic may apply in accordance with Article 1 of Protocol 2 to the Agreement to the products listed in Table I of that Protocol, originating in Iceland, shall be adjusted by the compensatory amount applied in trade between the Community as at present constituted and Greece.

Without prejudice to Protocol 5 to the Agreement, Switzerland will eliminate these duties on the tariff positions listed in the table attached to Protocol 5, subject to the approval, according to its internal legislation, of the necessary constitutional and legislative modifications, at the moment when the internal taxation enters into force.